Paracetamol From The Makers Of Disprin Reckitt Benckiser Ireland

Paracetamol, the active ingredient in Paracetamol From The Makers Of Disprin Reckitt Benckiser Ireland, is an analgesic and antipyretic presented as a tablet for oral use. It relieves mild to moderate pain and reduces fever in adults and children. GNH USA supplies Paracetamol From The Makers Of Disprin Reckitt Benckiser Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamol From The Makers Of Disprin Reckitt Benckiser Ireland is manufactured under strict EU regulations and distributed by GNH USA to meet global quality standards.

Paracetamol acts on the central pain‑relief and fever pathways and is used for several common conditions:

- Headache: provides relief from tension‑type and mild migraine headaches. - Fever: reduces elevated body temperature associated with infections. - Musculoskeletal pain: alleviates mild to moderate aches such as backache, sprains and strains. - Dental pain: eases discomfort following dental procedures. - Cold and flu symptoms: helps control fever and headache associated with viral upper respiratory infections. - Menstrual discomfort: lessens mild menstrual cramps and associated pain.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset reported by some users. - Rash: occasional skin redness or mild itching. - Elevated liver enzymes: transient rise in laboratory values. - Headache: paradoxical headache in rare cases. - Dizziness: light‑headed sensation, especially with rapid dose escalation.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury, particularly with overdose or chronic high‑dose use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Anaphylaxis: immediate hypersensitivity reaction, potentially life‑threatening. - Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia. - Hypotension: sudden drop in blood pressure after anaphylactic response.

When using Paracetamol, consider the following safety measures:

- Dosage limits: do not exceed the maximum daily amount recommended by a healthcare professional. - Liver health: avoid use in patients with severe hepatic impairment or active liver disease. - Alcohol consumption: limit alcohol intake as it may increase risk of liver toxicity. - Concomitant medications: review all other medicines for additional paracetamol content. - Pregnancy and lactation: use only under medical advice during pregnancy or while breastfeeding. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Paracetamol may interact with several medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect may raise bleeding risk. - Isoniazid: combined use can enhance hepatotoxic potential.

Moderate Interactions (Monitor Closely): - Antiepileptics (e.g., carbamazepine, phenytoin): may reduce paracetamol plasma concentrations. - HIV protease inhibitors: can alter metabolism, requiring liver function monitoring. - Oral contraceptives: may slightly increase hepatic enzyme activity. - High‑dose vitamin C: may affect renal clearance of paracetamol metabolites. - Rifampicin: induces enzymes that can lower paracetamol effectiveness.